RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Operating income

INSMED IncINSM

Market cap
$41.6B
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 2024-878+23.76%
Dec 31, 2023-710+55.17%
Dec 31, 2022-457+21.92%
Dec 31, 2021-375+41.42%
Dec 31, 2020-265+12.75%
Dec 31, 2019-235-23.46%
Dec 31, 2018-307+62.68%
Dec 31, 2017-189+8.95%
Dec 31, 2016-173+47.58%
Dec 31, 2015-117+34.49%
Dec 31, 2014-87+58.80%
Dec 31, 2013-55+29.64%
Dec 31, 2012-42-31.24%
Dec 31, 2011-62

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)